Revolution Medicines Inc.
RVMD | NASDAQ
$188.17
-$3.14 (-1.64%)
At close: Nov 2, 2026, 4:00 PM ET
$188.01
-$0.16 (-0.09%)
After-hours:
Nov 2, 2026, 4:38 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 742K | n/a | 3.82M | 7.01M | 15.33M | 3.36M | 9.12M | 7.58M | 9.46M | 1.1M | 8.7M | 10.13M |
Cost of Revenue | n/a | 4.54M | 4.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -4.54M | -4.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 742K | n/a | 3.82M | 7.01M | 15.33M | 3.36M | 9.12M | 7.58M | 9.46M | 1.1M | 8.7M | 10.13M |
Operating Income | -505.13M | -445.22M | -361.63M | -315.27M | -264.71M | -240.76M | -216.31M | -175.71M | -156.64M | -140.86M | -179.98M | -123.25M | -108.8M | -75.16M | -61.71M | -76.53M | -62.09M | -57.95M | -52.91M | -53.16M | -44.54M | -37.4M |
Interest Income | 35.58M | 19.51M | 21.29M | 22.08M | 22.4M | 24.92M | 21.23M | 20.41M | 21.49M | 23.76M | 18.67M | 10.95M | 10.5M | 7.06M | 5.08M | 2.91M | 867K | 302K | 237K | 223K | 236K | 233K |
Pretax Income | -644.37M | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -195.32M | -156.29M | -133.23M | -116M | -161.19M | -112.3M | -98.3M | -68.1M | -56.63M | -73.63M | -61.22M | -57.65M | -52.68M | -52.94M | -44.3M | -37.18M |
Net Income | -644.37M | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -194.57M | -156.29M | -133.23M | -116M | -161.54M | -108.43M | -98.3M | -68.1M | -56.51M | -73.33M | -61.22M | -57.65M | -52.68M | -52.94M | -44.3M | -37.18M |
Selling & General & Admin | 110.21M | 101.25M | 64.32M | 52.76M | 40.58M | 35.01M | 28.21M | 23.96M | 21.71M | 22.84M | 32.24M | 15.51M | 14.64M | 13.22M | 10.91M | 10.43M | 10.2M | 9.04M | 8.69M | 7.79M | 7.3M | 6.67M |
Research & Development | 394.92M | 343.97M | 292.61M | 262.51M | 224.13M | 205.75M | 188.1M | 151.75M | 134.93M | 118.02M | 148.48M | 107.74M | 97.98M | 68.95M | 66.13M | 69.46M | 61M | 56.49M | 53.68M | 46.47M | 45.94M | 40.86M |
Other Expenses | n/a | -4.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 505.13M | 440.69M | 356.92M | 315.27M | 264.71M | 240.76M | 216.31M | 175.71M | 156.64M | 140.86M | 180.73M | 123.25M | 112.62M | 82.17M | 77.04M | 79.89M | 71.21M | 65.53M | 62.37M | 54.26M | 53.23M | 47.53M |
Interest Expense | 23.78M | 12.2M | 11.94M | 11.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 505.13M | 445.22M | 361.63M | 315.27M | 264.71M | 240.76M | 216.31M | 175.71M | 156.64M | 140.86M | 180.73M | 123.25M | 112.62M | 82.17M | 77.04M | 79.89M | 71.21M | 65.53M | 62.37M | 54.26M | 53.23M | 47.53M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -753K | n/a | n/a | n/a | 343K | -3.87M | n/a | n/a | -123K | -297K | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 210.89M | 198.1M | 190.13M | 189.23M | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M | 94.83M | 89.16M | 84.69M | 74.28M | 74.16M | 73.82M | 73.54M | 73.4M | 70.42M |
Shares Outstanding (Diluted) | 210.89M | 198.1M | 190.13M | 189.23M | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M | 94.83M | 89.16M | 84.69M | 74.28M | 74.16M | 73.83M | 73.54M | 73.4M | 70.42M |
EPS (Basic) | -3.06 | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 | -0.81 | -0.70 | -1.14 | -0.99 | -0.92 | -0.62 | -0.63 | -0.87 | -0.81 | -0.77 | -0.71 | -0.72 | -0.60 | -0.53 |
EPS (Diluted) | -3.06 | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 | -0.81 | -0.70 | -1.14 | -0.99 | -0.92 | -0.62 | -0.63 | -0.87 | -0.81 | -0.77 | -0.71 | -0.72 | -0.60 | -0.53 |
EBITDA | -620.59M | -437.08M | -348.25M | -289.44M | -243.99M | -209.7M | -191.94M | -153.41M | -130.44M | -113.24M | -129.53M | -110.16M | -96.53M | -65.57M | -54.03M | -71.19M | -58.89M | -55.36M | -50.61M | -51.19M | -42.46M | -35.49M |
EBIT | -620.59M | -441.62M | -352.96M | -293.78M | -247.79M | -213.42M | -195.32M | -156.29M | -133.23M | -116M | -132.39M | -112.3M | -98.3M | -68.1M | -56.63M | -73.63M | -61.22M | -57.65M | -52.68M | -52.94M | -44.3M | -37.16M |
Depreciation & Amortization | n/a | 4.54M | 4.7M | 4.34M | 3.8M | 3.72M | 3.39M | 2.88M | 2.8M | 2.76M | 2.86M | 2.15M | 1.77M | 2.53M | 2.6M | 2.43M | 2.33M | 2.29M | 2.06M | 1.75M | 1.84M | 1.68M |
Add to Watchlist
Select watchlists to add or remove RVMD